Kim JS - Search Results

1

Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial.

Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB, Choi HS, Kim DW, Chang HJ, Kim DY, Jung KH, Kim TY, Kang GH, Chie EK, Kim SY, Sohn DK, Kim DH, Kim JS, Lee HS, Kim JH, Oh JH. Jeong SY, et al. Among authors: kim dw, kim dh, kim dy, kim ty, kim s, kim sy, kim js, kim jh. Lancet Oncol. 2014 Jun;15(7):767-74. doi: 10.1016/S1470-2045(14)70205-0. Epub 2014 May 15. Lancet Oncol. 2014. PMID: 24837215 Clinical Trial.

2

Screening of brain metastasis with limited magnetic resonance imaging (MRI): clinical implications of using limited brain MRI during initial staging for non-small cell lung cancer patients.

Kim SY, Kim JS, Park HS, Cho MJ, Kim JO, Kim JW, Song CJ, Lim SP, Jung SS. Kim SY, et al. Among authors: kim jo, kim js, kim jw. J Korean Med Sci. 2005 Feb;20(1):121-6. doi: 10.3346/jkms.2005.20.1.121. J Korean Med Sci. 2005. PMID: 15716616 Free PMC article.

3

Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer.

Kim K, Chie EK, Wu HG, Ha SW, Kim JS, Kim IA, Lee HP. Kim K, et al. Among authors: kim ia, kim js. Gynecol Oncol. 2006 Jun;101(3):398-402. doi: 10.1016/j.ygyno.2005.10.035. Epub 2005 Dec 5. Gynecol Oncol. 2006. PMID: 16330087 Clinical Trial.

4

Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53.

Kim IA, Shin JH, Kim IH, Kim JH, Kim JS, Wu HG, Chie EK, Ha SW, Park CI, Kao GD. Kim IA, et al. Among authors: kim ih, kim js, kim jh. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):940-9. doi: 10.1158/1078-0432.CCR-05-1230. Clin Cancer Res. 2006. PMID: 16467109

5

Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer.

Kim JS, Kim JS, Cho MJ, Yoon WH, Song KS. Kim JS, et al. J Korean Med Sci. 2006 Feb;21(1):52-7. doi: 10.3346/jkms.2006.21.1.52. J Korean Med Sci. 2006. PMID: 16479065 Free PMC article. Clinical Trial.

6

A histone deacetylase inhibitor, trichostatin A, enhances radiosensitivity by abrogating G2/M arrest in human carcinoma cells.

Kim IA, Kim JH, Shin JH, Kim IH, Kim JS, Wu HG, Chie EK, Kim YH, Kim BK, Hong S, Park SW, Ha SW, Park CI. Kim IA, et al. Among authors: kim ih, kim yh, kim js, kim bk, kim jh. Cancer Res Treat. 2005 Apr;37(2):122-8. doi: 10.4143/crt.2005.37.2.122. Epub 2005 Apr 30. Cancer Res Treat. 2005. PMID: 19956491 Free PMC article.

7

The sequencing of chemotherapy and radiotherapy in breast cancer patients after mastectomy.

Kim HJ, Kim JS, Chie EK, Noh DY, Bang YJ, Ha SW. Kim HJ, et al. Among authors: kim js. Tumori. 2010 Jan-Feb;96(1):28-33. doi: 10.1177/030089161009600105. Tumori. 2010. PMID: 20437854

8

Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).

Yeo SG, Kim DY, Kim TH, Chang HJ, Oh JH, Park W, Choi DH, Nam H, Kim JS, Cho MJ, Kim JH, Park JH, Kang MK, Koom WS, Kim JS, Nam TK, Chie EK, Kim JS, Lee KJ. Yeo SG, et al. Among authors: kim th, kim dy, kim js, kim jh. Ann Surg. 2010 Dec;252(6):998-1004. doi: 10.1097/SLA.0b013e3181f3f1b1. Ann Surg. 2010. PMID: 21107110

9

Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era.

Park JH, Kim YJ, Lee JO, Lee KW, Kim JH, Bang SM, Chung JH, Kim JS, Lee JS. Park JH, et al. Among authors: kim yj, kim js, kim jh. Lung Cancer. 2012 Jun;76(3):387-92. doi: 10.1016/j.lungcan.2011.11.022. Epub 2011 Dec 18. Lung Cancer. 2012. PMID: 22186628

10

Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer.

Kim JS, Lim JH, Kim JH, Im SA, Chie EK, Hwang JH, Kim TY, Bang YJ, Ha SW, Yoon YB. Kim JS, et al. Among authors: kim ty, kim jh. Cancer Chemother Pharmacol. 2012 Sep;70(3):381-9. doi: 10.1007/s00280-012-1918-7. Epub 2012 Jul 18. Cancer Chemother Pharmacol. 2012. PMID: 22806305 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,257 results

Search Page